UBS downgrades Novartis AG (NOVN) to a Hold
In a report released today, Matthew Weston from UBS downgraded Novartis AG (NOVN – Research Report) to a Hold, with a price target of ...
UBS cuts Novartis stock rating, lowers price target to CHF104
UBS analyst Matthew Weston downgraded Novartis (SIX:NOVN) shares from Buy to Neutral and reduced the price target from CHF111 ...